Joe Jimenez, CEO of Novartis discusses whether the U.S. affordable care act has increased the cost of business.» Read More
*Shares touch high of $34.19, valuing company at about $900 mln. It also analyzes tissue samples from clinical trials conducted by companies such as Novartis AG, Johnson& Johnson and Celgene Corp. Novartis accounts for more than 10 percent of Foundation Medicine's revenue.
William Dudley, president of the Federal Reserve Bank of New York, said the timeline that Fed Chairman Ben Bernanke articulated in June for scaling back the central bank's stimulus measures is "still very much intact," as long as the economy keeps improving. **APPLE INC, $488.59, up 4.5 pct.
U.S. stocks fell as comments by a Federal Reserve official and a looming political deadline in Washington outweighed earlier upbeat economic data from Germany and China. **APPLE INC, $488.59, up 4.5 pct. Apple sold 9 million iPhone 5 s and iPhone 5 c models in their first three days on the market, the most successful iPhone launch ever.
U.S. stocks fell as comments by a Federal Reserve official and a looming political deadline in Washington outweighed earlier upbeat economic data from Germany and China. **APPLE INC, $485.76, up 4 pct. Apple Inc said it sold 9 million iPhone 5 s and iPhone 5 c models in their first three days on the market, the most successful iPhone launch ever.
*New chairman reviewing Novartis' five business divisions. Novartis board member Pierre Landolt cited agrochemicals company Syngenta- formed in 2000 through the merger of Novartis' Agribusiness and Zeneca Agrochemicals- as a guide for how the drugmaker could unlock value for shareholders.
LONDON, Sept 19- Big drugmakers are seeking a boost from new four-in-one influenza vaccines that will be available for the first time this flu season. Sanofi, GlaxoSmithKline and AstraZeneca all have products ready to tap the new opportunity, while Novartis is lagging behind its rivals.
PARIS, Sept 19- European shares rose on Thursday, with one benchmark index rising to a five-year high after the U.S. Gold miners also jumped, tracking a sharp rally in the precious metal as the U.S. dollar fell.
*GlaxoSmithKline sales take biggest hit- industry insiders. SHANGHAI/ LONDON, Sept 18- A crackdown on corruption in China's pharmaceutical sector has hurt sales at international and local firms, with many doctors at Chinese hospitals refusing to see drug representatives for fear of being caught up in the widening scandal.
ZURICH/ BEIJING, Sept 17- Novartis said on Tuesday it would investigate allegations published in a Chinese newspaper that its eye care unit Alcon bribed doctors. "Alcon does not tolerate activities that are not in compliance with the laws and regulations in the markets where we operate," Novartis said in an emailed statement to Reuters.
MUMBAI, Sept 16- A third Ranbaxy Laboratories Ltd plant in India has been hit by a U.S. import ban over quality concerns, dealing a blow to the company's turnaround plans and threatening to hurt new launches and sales of medicines to its largest market.
*Christoph Franz to be elected at March 4 annual meeting. ZURICH, Sept 16- Roche has picked Deutsche Lufthansa Chief Executive Christoph Franz to succeed Franz Humer as chairman of its board, filling the top post at a time of change for the world's biggest maker of cancer drugs.
MUMBAI, Sept 16- A third Ranbaxy Laboratories Ltd plant in India has been sanctioned with an import alert ban from the U.S. Food and Drug Administration, triggering the worst single day fall in its stock on Monday and a brokerage downgrade.
NEW YORK, Sept 15- Nearly every oncologist can tell the story of cancer patients who beat the odds, responding so well to treatment that they continued to live many years disease-free, while most of their peers worsened and eventually died. David Solit decided to find out why.
LONDON, Sept 11- Reckitt Benckiser Group will be a major player in a coming shakeout of the global consumer health industry and has the capability to do sizeable deals, according to its chief executive.
SHANGHAI, Sept 11- Chinese insulin maker Gan& Lee Pharmaceuticals said on Wednesday it was investigating allegations published in a newspaper that it spent around 800 million yuan to bribe doctors to promote the firm's drugs over five years.
Data from the 17,135- patient study, comparing the safety and efficacy of Spiriva Respimat against a formulation of the drug given via the older HandiHaler device, were unveiled at the European Respiratory Society congress in Barcelona on Sunday.
After two decades of research, a treatment that slows or reverses the progression of Alzheimer's has proved elusive. The aging of the global population makes the need more urgent.
AMSTERDAM, Sept 3- The hunt for new heart drugs is losing momentum as resources are switched to other areas, notably cancer research, where investors get a better bang for their buck. Since the start of 2012, 17 new drugs been approved by the U.S. Food and Drug Administration for cancer compared with just three for heart disease.
AMSTERDAM, Sept 2- An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed.
Aug 29- The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis's multiple sclerosis drug, Gilenya.